Skip to content

Study · Not a test of the peptide alone · 1998

1 result

Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth.

Grellier P, De Galle B, Babajko S

Cancer research1 Apr 1998Cited by 40 (Europe PMC)

PMID9563481 (opens in a new tab)PepBankPUB-09563481

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, IGF-1 DES (des(1-3)IGF-I) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking IGF-1 DES (des(1-3)IGF-I).

  1. 01LabNot a test of IGF-1 DES (des(1-3)IGF-I) aloneIn vitro (cells)Mechanism

    In both neuroblastoma cell lines, IGFBP-6 cDNA expression depressed des IGF-I mitogenic effects compared with control cells.

    In plain wordsIn cells, IGFBP-6 gene expression reduced des IGF-I growth effects compared with control cells in both neuroblastoma cell lines.

    Outcome
    DecreaseMitogenic response to des IGF-I
    Study

    n: not reported in source

    IGR-N-91 and SK-N-SH neuroblastoma cells transfected with IGFBP-6 cDNA
    Comparator
    Control cells
    Outcome group
    Tumor growth · Cancer

    Source sentences

    Summary
    showed that the mitogenic effects of serum, IGF-I, IGF-II, and des (1-3) IGF-I, a truncated IGF-I analogue with no affinity for IGFBP-6, were depressed in both transfected cell lines.
    1 context sentence
    Summary · context
    We stably transfected IGR-N-91 and SK-N-SH neuroblastoma cells with an expression vector comprising IGFBP-6 cDNA, whose expression was placed under the control of the constitutive and ubiquitous cytomegalovirus promoter.

    In this study, IGF-1 DES (des(1-3)IGF-I) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking IGF-1 DES (des(1-3)IGF-I).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 2

    21 Oct 2026, 13:52 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.